Por: 10 WBNS Nation October 03, 2022
WASHINGTON — When patients with a deadly diagnosis and few treatment options have tried to get unapproved, experimental drugs, they have long faced a dilemma: Who will pay? Responsibility for funding so-called has always fallen to drugmakers, though many are unwilling or unable to make their drugs available for free to dying patients. After years of lobbying Congress, patients with the debilitating illness known as Lou Gehrig’s disease have... + full article
ABC News USA Business October 01, 2022
WASHINGTON -- When patients with a deadly diagnosis and few treatment options have tried to get unapproved, experimental drugs, they have long faced a dilemma: Who will pay?Responsibility for funding so-called compassionate use has always fallen to drugmakers, though many are... + más
NIH to fund unproven ALS drugs under patient-backed law | WPLG Local 10
NIH to fund unproven ALS drugs under patient-backed law | Associated Press
Associated Press USA Business October 01, 2022
WASHINGTON (AP) — When patients with a deadly diagnosis and few treatment options have tried to get unapproved, experimental drugs, they have long faced a dilemma: Who will pay?Responsibility for funding so-called compassionate use has always fallen to drugmakers, though many... + más
NIH to fund unproven ALS drugs under patient-backed law | ABC News
ABC News USA Health October 01, 2022
WPLG Local 10 USA Politics October 01, 2022
WASHINGTON – When patients with a deadly diagnosis and few treatment options have tried to get unapproved, experimental drugs, they have long faced a dilemma: Who will pay?Responsibility for funding so-called compassionate use has always fallen to drugmakers, though many are... + más
NBC 6 South Florida USA World October 01, 2022
Erin Hooley/Chicago Tribune/Tribune News Service via Getty Images Sandra Abrevaya helps her husband, Brian Wallach, walk at their home on Feb. 13, 2022, in Kenilworth, Illinois. His tattoo means ALS: You Gone. data-ellipsis=false> When patients with a deadly diagnosis and few... + más
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug wins FDA approval despite questionable data | ABC News
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
PennLive USA Nation September 30, 2022
WASHINGTON — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
About iurex | Privacy Policy | Disclaimer |